Do not stop or change your medication without speaking to a pharmacist or healthcare professional.
Anticipated Shortage

RABEPRAZOLE EC

SANIS HEALTH INC

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of RABEPRAZOLE EC in Canada?

A shortage of RABEPRAZOLE EC 20MG is expected: the manufacturer reported it to Health Canada as an anticipated shortage (last updated September 14, 2026), but it has not started yet.

Why is RABEPRAZOLE EC not available?

The reason the manufacturer reported: Disruption of the manufacture of the drug.

When will RABEPRAZOLE EC be available again?

The manufacturer's estimated resolution date is October 9, 2026. This is an estimate and can change; follow this page to get an email when the status changes.

Guide

Proton Pump Inhibitor (PPI) Shortage in Canada: Omeprazole, Pantoprazole, Rabeprazole

Why a shortage of one PPI brand rarely means the whole class is unavailable, when a pharmacist can swap manufacturers, and when it needs your prescriber.

Can I still get this?Possibly — same-ingredient product records found
StatusAnticipated Shortage
Same-ingredient products on file6 products
Expected resolution~11 days remaining (estimate)
Affected strength20MG
Last updated2026-09-14

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Closest Matches

DOM-RABEPRAZOLE EC

DOMINION PHARMACAL

20MG · DIN 02320460

Same strengthSame dosage formSame routeNo current shortage

RABEPRAZOLE EC

MELIAPHARM INC

20MG · DIN 02320622

Same strengthSame dosage formSame routeNo current shortage

Other Products

ABBOTT-RABEPRAZOLE

BGP PHARMA ULC

20MG · DIN 02422646

Same strengthDifferent dosage formSame routeNo current shortage

TARO-RABEPRAZOLE EC

SUN PHARMA CANADA INC

20MG · DIN 02419793

Same strengthDifferent dosage formSame routeNo current shortage

PARIET, ENTERIC-COATED TABLET 10MG

JANSSEN INC

10MG · DIN 02243796

Different strengthSame dosage formSame routeNo current shortage

TARO-RABEPRAZOLE

SUN PHARMA CANADA INC

10MG · DIN 02298074

Different strengthSame dosage formSame routeNo current shortage

What this means

Does this mean my pharmacy is already out of stock?

No — this shortage hasn't started yet. It's an early warning that supply may become tight, based on information from the manufacturer.

What should I do?

No action is needed yet. It's worth asking your pharmacist at your next refill whether they expect any disruption for this product.

⚠ Possible Recall or Safety Alert

Health Canada has issued a recall or safety alert matching this product. This match is based on product name similarity and may not be exact — confirm against your specific lot number before taking action.

DIN

02356538

Strength

20MG

Dosage Form

TABLET (ENTERIC-COATED)

Route

ORAL

Active Ingredient

RABEPRAZOLE SODIUM

See all RABEPRAZOLE SODIUM products →

Shortage Timeline

Approximate — based on the dates HPSC reports were last updated, not confirmed onset or resolution dates. Gaps between bars are periods with no shortage on file.

Active/anticipated Resolved

Shortage History